UniProt Q99584
Q99584
Q99584 (UniProt Q99584): 25 experimental structures on GenesisL1. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q99584
- Experimental structures
- 25
- Predicted models
- 0
Structures
25 records of Q99584 in the MolNFT archive: 25 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1YUR | Solution structure of apo-S100A13 (minimized mean structure) | solution nmr | A, B | — | — |
| 1YUR | Solution structure of apo-S100A13 (minimized mean structure) | solution nmr | A, B | — | — |
| 1YUS | Solution structure of apo-S100A13 | solution nmr | A, B | — | — |
| 1YUS | Solution structure of apo-S100A13 | solution nmr | A, B | — | — |
| 1YUT | Solution structure of Calcium-S100A13 (minimized mean structure) | solution nmr | A, B | — | — |
| 1YUT | Solution structure of calcium-S100A13 (minimized mean structure) | solution nmr | A, B | — | — |
| 1YUU | Solution structure of Calcium-S100A13 | solution nmr | A, B | — | — |
| 1YUU | Solution structure of calcium-S100A13 | solution nmr | A, B | — | — |
| 2EGD | Crystal structure of human S100A13 in the Ca2+-bound state | x-ray diffraction | A, B | — | — |
| 2EGD | Crystal structure of human S100A13 in the CA2+-bound state | x-ray diffraction | A, B | — | — |
| 2H2K | Crystal Structure Analysis of Human S100A13 | x-ray diffraction | A, B | — | — |
| 2H2K | Crystal structure analysis of human S100A13 | x-ray diffraction | A, B | — | — |
| 2K8M | S100A13-C2A binary complex structure | solution nmr | B, C | — | — |
| 2K8M | S100A13-C2A binary complex structure | solution nmr | B, C | — | — |
| 2KI4 | FGF1-S100A13 complex structure: key component in non-classical path way of FGF1 | solution nmr | B, C | — | — |
| 2KI4 | FGF1-S100A13 complex structure: key component in non-classical path way of FGF1 | solution nmr | B, C | — | — |
| 2KI6 | The FGF1-S100A13-C2A hetero-hexameric complex structure: A component in the non-classical pathway… | solution nmr | C, D | — | — |
| 2KI6 | The FGF1-S100A13-C2A hetero-hexameric complex structure: a component in the non-classical pathway… | solution nmr | C, D | — | — |
| 2KOT | Solution structure of S100A13 with a drug amlexanox | solution nmr | A, B | — | — |
| 2KOT | Solution structure of S100A13 with a drug amlexanox | solution nmr | A, B | — | — |
| 2L5X | Solution structure of IL1A-S100A13 complex | solution nmr | B, C | — | — |
| 2L5X | Solution structure of IL1A-S100A13 complex | solution nmr | B, C | — | — |
| 2LE9 | RAGEC2-S100A13 tetrameric complex | solution nmr | B, C | — | — |
| 2LE9 | RAGEC2-S100A13 tetrameric complex | solution nmr | B, C | — | — |
| Q99584 | AlphaFold monomer V2.0 prediction for protein S100-A13 (Q99584) | — | — | — |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.